Overture Life. Estados Unidos.
Education
1991: Ph.D. in Human Genetics. University of Pittsburgh, Pennsylvania, USA.
1987: "Licenciado en Ciencias Biologicas" (Equivalent to a Master in Science). University of Barcelona, Barcelona, Spain
Present employment and positions:
- COO, Overture Life, 12/15/2017 – to date
- Professor Adjunct, Yale University Dept. Ob. Gyn. and Reprod. Science, 7/1/2017- to date
Past employment and positions:
- CSO, CooperGenomics, CooperSurgical companies: From 10/12/2016 to 11/21/2017.
- President of Reprogenetics, a CooperSurgical company: From 8/11/2015 to 10/11/2016.
- CEO of Reprogenetics: From 12/15/2014 to 8/10/2015
- CSO of Recombine: From 1/2012 – 12/2013
- President of Reprogenetics: From 12/31/01 to 12/15/2014.
- Director Preimplantation Genetics at The Institute for Reproductive Medicine and Science, Saint Barnabas Medical Center, 101 Old Shorts Hills road, suite 501, West Orange, NJ-07052: from 5/1/95 to 12/31/03.
- Instructor of Genetics in OB/GYN at Cornell University Medical College, Department of OB/GYN, 1300 York Ave, New York, N.Y-10021: from 7/1/93 to 4/30/95.
- Postdoctoral Associate in OB/GYN at Cornell University Medical College, Department of OB/GYN, 1300 York Ave, New York, N.Y-10021: From 1/10/91 to 6/30/93.
- Research Assistant and Ph.D. student at The West Penn Hospital. Department of Medical Genetics. 4800 Friendship Ave., Pittsburgh, PA-15224: From 8/31/88 to 9/30/91.
Entrepreneurial activity
• Co-Founded Overture Life in 2017 with Martin Varsavsky and Jose Horcajadas.
• Co-Founded MedAnswers in 2017 with Alice Crisci.
• Co-Founded Phosphorus in 2016 with Alex Bisignano.
• Co-Founded Recombine in 1/2012 with Alex Bisignano and Kelly Ketterson. Sold to CooperCompanies Inc (NYSE: COO) on 5/2016 for 85M:
http://www.nasdaq.com/article/cooper-companies-arm-acquires-recombine-assets-for-85m-cm627397
• Co-Founded Reprogenetics in 12/2001 with Jacques Cohen and David Sable. Sold to CooperCompanies Inc (NYSE: COO) on 8/2015 for 46.5M:
http://globenewswire.com/news-release/2015/08/10/759444/10145479/en/The-Cooper-Companies-Women-s-Health-Care-Unit-Acquires-Reprogenetics.html
Company boards
Overture Life, Board of directors: 12/2017 - to present
Aggio, BOA: 2018 – to present
Previvo, Board of directors and Scientific advisory board: 12/2017- to present
Phosphorus, Board of directors: 2016 - to present
MedAnswers, Board of directors: 2014 - to present
CooperSurgical, Scientific advisory board: 2015- 11/21/2017
Recombine, Board of directors: 2012-2016
Cytotest, Scientific advisory board: 2009-2011
Reprogenetics, Board of directors: 2001-2015
Clinical experience and Accreditations
- Accredited Laboratory Director in the category of Genetic Testing, modality molecular and modality cytogenetics for Preimplantation Genetic Diagnosis. New York State Department of Health. CQ code: MUNNS1.
- 2001-to date: Laboratory Director of Preimplantation Genetic Diagnosis, Reprogenetics, LLC
- 1995-2003: Laboratory Director of Preimplantation Genetic Diagnosis at The Institute for Reproductive Medicine and Science, Saint Barnabas Medical Center, 101 Old Shorts Hills road, suite 501, West Orange, NJ-07052.
- 1993-1995: Lab supervisor performing clinical Preimplantation Genetic Diagnosis at Cornell University Medical College. Department of OB/GYN, 1300 York Ave, New York, N.Y-10021.